Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients - PWR 12.02.2022
powernephron
Published on Dec 13, 2022
Dr. Karen Shalansky, Dr. Kevin Kwok, Dr. Hilary Wu present, "Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients."
Category
- Your Subscription
powernephron -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
24:13
Gestational and Chronic Hypertension - CRASH! Medical Review Series
9 views 612 days ago -
47:17
Renin angiotensin system blockade in COVID-19: A tumultuous year in review
11 views 1044 days ago -
35:15
Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
12 views 1068 days ago -
25:08
HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
11 views 864 days ago -
52:24
New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF
13 views 1044 days ago -
30:35
Christopher Blosser, MD - Cancer in Patients with Kidney Disease
11 views 867 days ago